Real-time enrollment status for this non-hodgkin lymphoma refractory/ relapsed clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:30 PM UTC
| NCT Number | NCT07121946 |
| Recruiting Status | Recruiting |
| Condition | Non-Hodgkin Lymphoma Refractory/ Relapsed |
| Phase | PHASE1 |
| Target Enrollment | 42 participants |
| Active Locations | 6 sites in the US |
| Sponsor | LTZ Therapeutics, Inc. |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of August 29, 2026: Clinical trial NCT07121946 is currently recruiting participants. This phase1 study for non-hodgkin lymphoma refractory/ relapsed is actively seeking new participants at 6 locations across the United States. The study is sponsored by LTZ Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07121946 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07121946 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.